Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring

Hypertension

Volumn 57, Issue 5, 2011, Pages 898-902

  De La Sierra, Alejandro ^a   Segura, Julián ^b   Banegas, José R ^c   Gorostidi, Manuel ^d   De La Cruz, Juan J ^c   Armario, Pedro ^e   Oliveras, Anna ^f   Ruilope, Luis M ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL GENERAL DE CATALUNYA   (Spain)

^f HOSPITAL DEL MAR   (Spain)

Author keywords

ambulatory blood pressure monitoring; cardiovascular risk; circadian pattern; resistant hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; REGISTER; RESISTANT HYPERTENSION; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; URINARY ALBUMIN EXCRETION; URINARY EXCRETION; WHITE COAT HYPERTENSION;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RISK; SEX FACTORS; SMOKING; SPAIN; STATISTICS, NONPARAMETRIC;

EID: 79955481070     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.168948     Document Type: Article

References (30)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403-1419.
2. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resis-tant? Am J Hypertens. 2001;14:1263-1269.
3. Hernández del Rey R, Armario P, Martín-Baranera M, Castellanos P. Clustering of cardiovascular risk factors and prevalence of metabolic syndrome in subjects with resistant hypertension [in Spanish]. Med Clín (Barc). 2006;127:241-245. (Pubitemid 44343354)
4. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. True resistant Hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18:1534-1540. (Pubitemid 41814672)
5. Oliveras A, Armario P, Hernandez-del Rey R, Arroyo JA, Poch E, Larrousse M, Roca-Cusachs A, De la Sierra A. Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens. 2010; 24:27-33.
6. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, Caldarella MP, Neri M, Cuccurullo F, Mezzetti A. Car-diovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:1422-1428. (Pubitemid 41566669)
7. Salles GF, Cardoso CRL, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168:2340-2346.
8. Redón J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998;31:712-718.
9. Sierra C, De la Sierra A, Sobrino J, Segura J, Banegas JR, Gorostidi M, Ruilope LM. Ambulatory blood pressure monitoring (CABPM): clinical characteristics of 31,530 patients [in Spanish]. Med Clin (Barc). 2007; 129:1-5. (Pubitemid 47421805)
10. Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, De la Sierra A, De la Cruz JJ, Goros tidi M, Sarría A, Ruilope LM, for the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49:62-68. (Pubitemid 46360342)
11. Gorostidi M, Sobrino J, Segura J, Sierra C, De la Sierra A, Hernández del Rey R, Vinyoles E, Galcerán JM, López-Eady MD, Marín R, Banegas JR, Sarría A, Coca A, Ruilope LM, on behalf of the Spanish Society of Hypertension ABPM Registry investigators. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977-984. (Pubitemid 46573116)
12. Vinyoles E, Felip A, Pujol E, De la Sierra A, Dura R, Hernandez del Rey R, Sobrino J, Gorostidi M, de la Figuera M, Segura J, Banegas JR, Ruilope LM, on behalf of the Spanish Society of Hypertension ABPM Registry. Clinical characteristics of isolated clinic hypertension. J Hypertens. 2008;26:438-445.
13. De la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, de la Cruz JJ, Sobrino J, Llisterri JL, Alonso J, Vinyoles E, Pallarés V, Sarría A, Aranda P, Ruilope LM. Prevalence and factors associated with cir-cadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53:466-472.
14. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension Working Group on Blood Pressure Monitoring. J Hypertens. 2003;21: 821-848.
15. De la Sierra A, Gorostidi M, Marin R, Redon J, Banegas JR, Armario P, Garcia-Puig J, Zarco J, Llisterri JL, Sanchos C, Abarca B, Palomo V, Gomis R, Otero A, Villar F, Honorato J, Tamargo J, Lobos JM, Macías- Núñez J, Sarria A, Aranda P, Ruilope LM. Evaluation and man-agement of hypertension in Spain: a consensus guide [in Spanish]. Med Clin (Barc). 2008;131:104-116.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamo-poulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; Management ofArterial Hypertension of the European Society of Hypertension; European Society of Car-diology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Car-diology (ESC). J Hypertens. 2007;25:1105-1187. (Pubitemid 46924065)
17. Veglio F, Rabbia F, Riva P, Martini G, Genova GC, Milan A, Paglieri C Carra R, Chiandussi L. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens. 2001;23:203-211. (Pubitemid 32374602)
18. Muxfeldt ES, Nogueira Ada R, Salles GF, Bloch KV. Demographic and clinical characteristics of hypertensive patients in the internal medicine outpatient clinic of a university hospital. Sao Paulo Med J. 2004;122: 87-93. (Pubitemid 39172953)
19. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, Papademetriou V, Probstfield J, Wright JT, Alderman MH, Weiss RJ, Piller L, Bettencourt J, Walsh SM, for the ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens. 2002;4:393-404. (Pubitemid 35469393)
20. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin Outcome Study. Hypertension. 2005;46:156-161. (Pubitemid 40946507)
21. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ, for the Subcommittee of Profes-sional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: part 1-blood pressure measurement in humans: a statement for professionals from the Subcom-mittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142-161. (Pubitemid 40066429)
22. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe Trial Investigators. Predicting car-diovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539-546. (Pubitemid 29380290)
23. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801. (Pubitemid 24363980)
24. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama Study. J Hypertens. 2002;20:2183-2189. (Pubitemid 35388236)
25. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. J Hypertens. 2003;8:181-185. (Pubitemid 41623175)
26. Muxfeldt ES, Cardoso CR, Salles GF. Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Arch Intern Med. 2009;169:874-880.
27. Hermida RC, Ayala DE, Calvo C, Lopez JE, Mojon A, Fontao MJ, Soler R, Fernandez JR. Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension. Hypertension. 2005;46:1053-1059.
28. Stergiou GS, Nasothimiou EG. Does dosing antihypertensive drugs at night alter renal or cardiovascular outcome: do we have the evidence? Curr Opin Nephrol Hypertens. 2008;17:464-469.
29. Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC Study. Chronobiol Int. 2010;27:1629-1651.
30. O'Brien E. Ambulatory blood pressure measurement: the case for imple-mentation in primary care. Hypertension. 2008;51:1435-1441.